ObvioHealth and Renovia conducted a groundbreaking study on the efficacy of an at-home medical device for the treatment of stress and mixed urinary incontinence. Read more below to understand how we delivered a successful, fully virtual clinical trial in the midst of the pandemic.

ObvioHealth successfully conducted a clinical trial for RedHill Biopharma to test the safety and efficacy of an oral medication for the treatment of COVID-19 symptoms. We designed this decentralized study to be conducted where the majority of patients recover from illness—in their homes. When the trial was launched in 2021, its unique combination of home health visits, electronic patient-reported outcomes (ePRO), and remote monitoring devices was pioneering—COVID-19 studies were typically conducted inside hospitals.

A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).

ObvioHealth was asked to conduct an observational study of infant crying and fussing.

A global consumer-health brand sought to gather consumer-centric claims supported by real-world evidence in preparation of a television ad launch for its diaper-rash ointment.